您正在浏览的是香港网站,香港证监会BJA907号,投资有风险,交易需谨慎
市场资讯

市场资讯

首页市场资讯个股相关资讯

Cellectis SA (CLLS)

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and Andr Choulika on February 20, 1999 and is he